Speaking Faculty

Aris Persidis, Ph.D.President, Biovista

Clare Thibodeaux, Ph.D.Vice President, Scientific Affairs, Cures Within Reach

Dr. Bruce BloomFounder, Cures Within Reach, Chief Collaboration Officer, Healx

Laura Kleiman, Ph.D.Founder & CEO, Reboot Rx

G. Sitta Sittampalam, Ph.D.Senior Advisor to the Director, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health

Christopher Lipinski, Ph.D.Scientific Advisor, Melior Discovery

Eyal Barash, JDFounder, Barash Law

James Doyle, Ph.D.Co-Founder and CEO, Modelis

Smith Heavner, Ph.D., RNScientific Director, CURE Drug Repurposing Collaboratory (CDRC), Critical Path Institute

Stephen CaseyFounder & CEO, The 505(b)(2) Platform

Michael DerbyManaging Partner, TardiMed Sciences

Heather Mortiboys, Ph.D.Professor of Cellular Neuroscience & Metabolism, University of Sheffield

David H. Crean, Ph.D., MBAManaging Director, Equitos Venture Partners

Malina Bakowski, Ph.D.Principal Investigator, Calibr at Scripps Research

Tomas Babak, Ph.D.Chief Executive Officer, Leapfrog Bio

Sven Jacobson, MBACEO, Woolsey Pharmaceuticals, Co-Founder & CEO, Martin Pharmaceuticals

Sundeep Dugar, Ph.D.President & Chief Executive Officer, Aayam Therapeutics

Yossef Av-Gay, Ph.D.Professor, Departments of Medicine and Microbiology and Immunology, University of British Columbia

Santiago Ramon-Garcia, Ph.D.ARAID Investigator, Research and Development Agency of Aragon (ARAID) Foundation

John SemanChief Executive Officer, Revitale Pharma

Yi Rang Kim, MD, Ph.D.Founder & CEO, ONCOCROSS

Martin de Kort, Ph.D.Senior Scientific Program Manager Translational Medicine & Drug Development, EATRIS

Jaykumar MenonChair and Co-founder, Open Source Pharma Foundation

Dr. Richard WyseDirector of Clinical Development, Cure Parkinson's